Company

PolTREG S.A.

Biotechnology Research Gdansk, Pomorskie, Pl 40 employees

Employees: 40
Contacts: 3
Emails: 3
Phones: 1

poltreg.com LinkedIn

PolTREG S.A. Overview

Headquarters: Gdansk, Pomorskie, Pl
Website: poltreg.com
Industry: Biotechnology Research
Employees: 40
Founded: 2015
Funding: ,
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

formed a strategic alliance with Swiss company Antion Biosciences SA to develop next-generation allogeneic TREG therapies

About PolTREG S.A.

PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. PolTREG is the most advanced company in TREGS cellular therapies worldwide, breakthrough therapies for type 1 diabetes (T1D) and multiple sclerosis (MS). PolTREG has very promising results regarding the safety and efficacy of TREGS therapy (completed phase I/II clinical trials in T1D and phase I in MS), ready for the next phase of trials. The company is after EMA Scientific Advice procedure.

PolTREG S.A. Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 1; 33.3% coverage

PolTREG S.A. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Marcin Mierzwinski		Warsaw, Mazowieckie, Poland	Email
Wojciech Golak		Warsaw, Mazowieckie, Poland	Email
Dan Shelly	Chief Business Development Officer @	Cincinnati, Ohio, United States	Email Phone